AMGEN INC

For the period ended Mar 31, 2025. Filed May 2, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 2, 2025

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

	Numberof sharesof commonstock	Commonstock andadditionalpaid-in capital	Accumulateddeficit	Accumulatedothercomprehensive loss	Total
Balance as of December 31, 2024	536.9	$33,533	$(27,590)	$(66)	$5,877
Net income	—	—	1,730	—	1,730
Other comprehensive loss, net of taxes	—	—	—	(165)	(165)
Dividends declared on common stock ($2.38 per share)	—	—	(1,280)	—	(1,280)
Issuance of common stock in connection with equity award programs	0.8	42	—	—	42
Stock-based compensation expense	—	85	—	—	85
Tax impact related to employee stock-based compensation expense	—	(82)	—	—	(82)
Balance as of March 31, 2025	537.7	$33,578	$(27,140)	$(231)	$6,207

	Numberof sharesof commonstock	Commonstock andadditionalpaid-in capital	Accumulateddeficit	Accumulatedothercomprehensiveloss	Total
Balance as of December 31, 2023	535.4	$33,070	$(26,549)	$(289)	$6,232
Net loss	—	—	(113)	—	(113)
Other comprehensive income, net of taxes	—	—	—	99	99
Dividends declared on common stock ($2.25 per share)	—	—	(1,208)	—	(1,208)
Issuance of common stock in connection with equity award programs	1.0	34	—	—	34
Stock-based compensation expense	—	103	—	—	103
Tax impact related to employee stock-based compensation expense	—	(125)	—	—	(125)
Balance as of March 31, 2024	536.4	$33,082	$(27,870)	$(190)	$5,022

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.